Trade Bristol Myers ^BMY

Bristol Myers Squibb Company $BMY Shares Purchased by Natixis Advisors LLC

WCG Wealth Advisors LLC Has $2.56 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Cibc World Market Inc. Has $26.92 Million Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Arrowpoint Investment Partners Singapore Pte. Ltd. - Zolmax

UBS Remains a Buy on Olema Pharmaceuticals (OLMA)

Bristol Myers Squibb Adds New Late Stage Oncology Opportunity With Izalontamab

3 Value Stocks We Think Twice About

Sivia Capital Partners LLC Raises Position in Bristol Myers Squibb Company $BMY

Bristol-Myers Squibb Cancer Wins Test Investor Patience On Valuation

CIBC Asset Management Inc Buys 196,274 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb (BMY) Is Down 6.2% After EU Opdivo Frontline Hodgkin Lymphoma Approval - What's Changed - Simply Wall St News

Westpac Banking Corp Purchases 46,386 Shares of Bristol Myers Squibb Company $BMY

Bank of New York Mellon Corp Has $1.32 Billion Stock Position in Bristol Myers Squibb Company $BMY

Rothschild Wealth LLC Purchases New Stake in Bristol Myers Squibb Company $BMY - Daily Political

Westpac Banking Corp Raises Stock Position in Bristol Myers Squibb Company $BMY - Daily Political

BMS patents new CAMK2 inhibitors | BioWorld

Is Bristol-Myers Squibb Stock Underperforming the Dow?

Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY) - Daily Political

Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY)

BMY: Late Stage Milvexian Readouts And Pipeline Wins Will Drive Re Rating

BMY: Positive Interim Results for Bristol Myers' Iza-bren in Can

Is BMY Undervalued? DCF Says Worth $74

BMS' bispecific ADC puts TROP2 drugs on notice

ASCO 2026: Transitioning from PD - 1 Replication to "Defining the Next - Generation Framework" in China's Immunotherapy: Three Routes

Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax

Bristol Myers Squibb CEO on $15B deal with China's Hengrui Pharma

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) | Morningstar

Sfmg LLC Decreases Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb CEO warns Australia risks losing access to life-saving medicines, must reform Pharmaceutical Benefits Scheme

MUFG Securities EMEA plc Raises Holdings in Bristol Myers Squibb Company $BMY

Black Swift Group LLC Purchases New Position in Bristol Myers Squibb Company $BMY

Peapack Gladstone Financial Corp Has $24.27 Million Stake in Bristol Myers Squibb Company $BMY - Daily Political

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Evaluating the Clinical and Humanistic Impact of a Self-Care and Minor Ailment Service (MAS)

BMY: Promising Phase 2 Results for Pumitamig in Lung Cancer Treatment

BMY Shows Promising Results in Lung Cancer Trial

Railway Pension Investments Ltd Has $63.89 Million Stock Holdings in Bristol Myers Squibb Company $BMY

Impact Partnership Wealth LLC Cuts Stake in Bristol Myers Squibb Company $BMY - Zolmax

Bristol Myers Squibb Company $BMY Shares Sold by Impact Partnership Wealth LLC

How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial

Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains

Eurizon Capital SGR S.p.A. Takes $82.35 Million Position in Bristol Myers Squibb Company $BMY - Zolmax

Eurizon Capital SGR S.p.A. Acquires New Holdings in Bristol Myers Squibb Company $BMY

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial | Valuespectrum.com

C4 Therapeutics (CCCC) Hits 52-Week High Following BMY Trial Success

BMY: New Insights from Bristol Myers Squibb's Phase 3 Cancer Tri

Bristol Myers drug delays myeloma progression in hard to treat patients

SBI Okasan Asset Management Co.Ltd. Takes $1.19 Million Position in Bristol Myers Squibb Company $BMY

Ilmarinen Mutual Pension Insurance Co Decreases Stake in Bristol Myers Squibb Company $BMY

Intech Investment Management LLC Acquires 931,322 Shares of Bristol Myers Squibb Company $BMY

Bristol-Myers Squibb (BMY) Partners with Anthropic

BMS' mezigdomide doubles PFS in multiple myeloma | BioWorld

Geode Capital Management LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY

King Luther Capital Management Corp Buys 13,300 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial

12 Most Undervalued Stocks to Invest In

Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference | National | reflector.com

BMO Capital Maintains Market Perform Rating on Bristol-Myers (BMY) After Earnings Beat

Flputnam Investment Management Co. Increases Position in Bristol Myers Squibb Company $BMY

Allstate Corp Raises Stake in Bristol Myers Squibb Company $BMY

Poinciana Advisors Group LLC Purchases New Position in Bristol Myers Squibb Company $BMY - Stock Observer

BMS-Hengrui deal strikes panic in Washington | BioWorld

Bristol Myers Squibb ASCO Data Puts Oncology Pipeline In Investor Focus

JW Therapeutics CEO Says China Pharma Partnerships Unaffected by Tech Curbs

Uveal Melanoma Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

Tempus AI (TEM) Valuation Check After New Prostate Test Launch And Expanded Bristol Myers Squibb Collaboration

5 Best Retirement Stocks to Buy Now

Bristol Myers Squibb Company $BMY Shares Acquired by EverSource Wealth Advisors LLC

Legal & General Group Plc Buys 290,289 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial

Is Bristol-Myers Squibb (BMY) One of the Best Dividend Stocks to Invest in According to Hedge Funds?

Bristol Myers Squibb Company $BMY Position Trimmed by Associated Banc Corp

How Bristol Myers Squibb's Claude AI Deployment Across its Pipeline (BMY) Has Changed Its Investment Story

Mizuho Markets Cayman LP Invests $608,000 in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Position Raised by LSV Asset Management - Stock Observer

Bristol Myers Squibb Company $BMY Stock Position Raised by Legato Capital Management LLC - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic Partnership

BMY Stock Sees Minor Dip After Six-Day Rally

Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.

Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks

1 Profitable Stock to Keep an Eye On and 2 We Brush Off

Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise - Stock Observer

Bristol Myers Squibb AI Deal With Anthropic And What It Means For BMY

23,109 Shares in Bristol Myers Squibb Company $BMY Acquired by Keudell Morrison Wealth Management

24,461 Shares in Bristol Myers Squibb Company $BMY Purchased by Ignite Planners LLC

Pzena Investment Management LLC Has $967.87 Million Holdings in Bristol Myers Squibb Company $BMY

IFP Advisors Inc Buys 18,060 Shares of Bristol Myers Squibb Company $BMY

Global Retirement Partners LLC Buys 60,544 Shares of Bristol Myers Squibb Company $BMY

Heritage Investors Management Corp Reduces Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Week ahead: Fed to hike 100bps into a recession?

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk